Critical Path Institute 2026 Conference

The Critical Path Institute>>> is hosting its 2026 Global Impact Conference (CGIC) in United States — Washington (state)>>> from September 15-17. The conference will convene leaders from regulatory agencies, industry, academia, and advocacy to address challenges in drug development, focusing on establishing a new paradigm for generating evidence of efficacy and safety. Keynote speakers include Michael Davis (physician)>>>, acting director of the United States — Food and Drug Administration>>>'s Center for Drug Evaluation and Research, and Janet Woodcock>>>, former principal deputy commissioner of the United States — Food and Drug Administration>>>. The agenda covers topics such as artificial intelligence, real-world data, digital health technologies, biomarkers, and individualized therapies, with a dedicated session on C-Path's 'One to Millions' initiative. Klaus Romero>>>, CEO of Critical Path Institute>>>, highlighted the conference's goal to transform evidence generation to deliver treatments faster and more reliably.